United States Pharmaceuticals

Liquidia Technologies Inc (LQDA)

Track

Track

Liquidia Technologies Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred in November 2020, when Eshelman Ventures, LLC executed multiple sales of company shares. Prior to those divestments, the same entity engaged in significant purchasing throughout early 2020.
Ticker: LQDA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Sale
Price
236.27
Quantity 19,486 +40.2%
Value US$557,754
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Sale
Price
20.76
Quantity 84,196 +14.1%
Value US$1,512,072
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Sale
Price
461.09
Quantity 64,783 +43.0%
Value US$3,257,369
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 1,875,000 +36.3%
Value US$15,000,000
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Purchase
Price
5.28
Quantity 44,250 +33.7%
Value US$233,715
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Purchase
Price
4.85
Quantity 35,000 +36.3%
Value US$169,740
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Purchase
Price
4.96
Quantity 7,223 +8.1%
Value US$35,792
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Purchase
Price
4.89
Quantity 45,000 +102.0%
Value US$220,122
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Purchase
Price
4.87
Quantity 30,000 +212.8%
Value US$146,112
2.9
Eshelman Ventures, LLC Large shareholder
Transaction date
Purchase
Price
4.76
Quantity 14,100 +inf%
Value US$67,106
3.9
Canaan VIII LP Large shareholder
Transaction date
Purchase
Price
3.13
Quantity 319,488 +12.3%
Value US$999,997
Albury Timothy SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
6.00
Quantity 6,762 -14.8%
Value US$40,572
Albury Timothy SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
6.50
Quantity 466 -1.2%
Value US$3,029
Albury Timothy SVP, Chief Accounting Officer Officer
Transaction date
Sale
Price
7.06
Quantity 920 -2.4%
Value US$6,495
Maynor Benjamin SVP, Research and Development Officer
Transaction date
Planned sale
Price
19.86
Quantity 2,137 -33.9%
Value US$42,441
Maynor Benjamin SVP, Research and Development Officer
Transaction date
Planned sale
Price
18.95
Quantity 50 -0.8%
Value US$948
2.4
GORDON KEVIN K President and CFO Officer
Transaction date
Planned sale
Price
18.09
Quantity 438 -0.3%
Value US$7,923
2.4
GORDON KEVIN K President and CFO Officer
Transaction date
Planned sale
Price
16.83
Quantity 212 -0.1%
Value US$3,568
2.4
GORDON KEVIN K President and CFO Officer
Transaction date
Planned sale
Price
15.83
Quantity 293 -0.2%
Value US$4,638
2.4
GORDON KEVIN K President and CFO Officer
Transaction date
Planned sale
Price
14.84
Quantity 8,355 -4.9%
Value US$123,988
2.4
GORDON KEVIN K President and CFO Officer
Transaction date
Planned sale
Price
14.14
Quantity 2,967 -1.7%
Value US$41,953
Kirsch Arthur S Non-Executive Director
Transaction date
Purchase
Price
18.50
Quantity 895 +81.0%
Value US$16,558
Kirsch Arthur S Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 105 +10.5%
Value US$1,890
Kirsch Arthur S Non-Executive Director
Transaction date
Purchase
Price
18.25
Quantity 1,000 +inf%
Value US$18,250
Canaan VIII LP Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 727,273 +39.6%
Value US$8,000,003
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +28.1%
Value US$6,000,005
BASKETT FOREST Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +28.1%
Value US$6,000,005
Bloch Stephen M Non-Executive Director
Transaction date
Purchase
Price
11.00
Quantity 727,273 +39.6%
Value US$8,000,003
BARRIS PETER J Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +28.1%
Value US$6,000,005
New Enterprise Associates 12, Limited Partnership Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +28.1%
Value US$6,000,005
GLAXOSMITHKLINE PLC
Transaction date
Purchase
Price
11.00
Quantity 148,818 +31.3%
Value US$1,636,998
KERINS PATRICK J Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +28.1%
Value US$6,000,005
BARRETT M JAMES Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 545,455 +28.1%
Value US$6,000,005
Alexandria Venture Investments, LLC Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 136,364 +52.5%
Value US$1,500,004
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-11-27 2020-11-25 S Sale
2.9
Eshelman Ventures, LLC
Large shareholder
19,486 +40.2%
236.27
US$557,754 		19,486 +40.2% 236.27 US$557,754
2020-11-25 2020-11-24 S Sale
2.9
Eshelman Ventures, LLC
Large shareholder
84,196 +14.1%
20.76
US$1,512,072 		84,196 +14.1% 20.76 US$1,512,072
2020-11-24 2020-11-23 S Sale
2.9
Eshelman Ventures, LLC
Large shareholder
64,783 +43.0%
461.09
US$3,257,369 		64,783 +43.0% 461.09 US$3,257,369
2020-07-02 2020-07-02 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
1,875,000 +36.3%
8.00
US$15,000,000 		1,875,000 +36.3% 8.00 US$15,000,000
2020-04-07 2020-04-06 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
44,250 +33.7%
5.28
US$233,715 		44,250 +33.7% 5.28 US$233,715
2020-04-07 2020-04-03 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
35,000 +36.3%
4.85
US$169,740 		35,000 +36.3% 4.85 US$169,740
2020-04-03 2020-04-02 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
7,223 +8.1%
4.96
US$35,792 		7,223 +8.1% 4.96 US$35,792
2020-04-03 2020-04-01 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
45,000 +102.0%
4.89
US$220,122 		45,000 +102.0% 4.89 US$220,122
2020-04-01 2020-03-31 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
30,000 +212.8%
4.87
US$146,112 		30,000 +212.8% 4.87 US$146,112
2020-04-01 2020-03-30 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
14,100 +inf%
4.76
US$67,106 		14,100 +inf% 4.76 US$67,106
2020-01-10 2019-12-27 B Purchase
3.9
Canaan VIII LP
Large shareholder
319,488 +12.3%
3.13
US$999,997 		319,488 +12.3% 3.13 US$999,997
2019-08-26 2019-08-22 S Sale Albury Timothy

SVP, Chief Accounting Officer

Officer
6,762 -14.8%
6.00
US$40,572 		6,762 -14.8% 6.00 US$40,572
2019-08-15 2019-08-14 S Sale Albury Timothy

SVP, Chief Accounting Officer

Officer
466 -1.2%
6.50
US$3,029 		466 -1.2% 6.50 US$3,029
2019-08-15 2019-08-13 S Sale Albury Timothy

SVP, Chief Accounting Officer

Officer
920 -2.4%
7.06
US$6,495 		920 -2.4% 7.06 US$6,495
2019-03-01 2019-02-28 PlS Planned sale
Maynor Benjamin

SVP, Research and Development

Officer
2,137 -33.9%
19.86
US$42,441 		2,137 -33.9% 19.86 US$42,441
2019-03-01 2019-02-28 PlS Planned sale
Maynor Benjamin

SVP, Research and Development

Officer
50 -0.8%
18.95
US$948 		50 -0.8% 18.95 US$948
2019-02-22 2019-02-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
438 -0.3%
18.09
US$7,923 		438 -0.3% 18.09 US$7,923
2019-02-22 2019-02-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
212 -0.1%
16.83
US$3,568 		212 -0.1% 16.83 US$3,568
2019-02-22 2019-02-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
293 -0.2%
15.83
US$4,638 		293 -0.2% 15.83 US$4,638
2019-01-24 2019-01-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
8,355 -4.9%
14.84
US$123,988 		8,355 -4.9% 14.84 US$123,988
2019-01-24 2019-01-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
2,967 -1.7%
14.14
US$41,953 		2,967 -1.7% 14.14 US$41,953
2018-11-15 2018-11-14 B Purchase Kirsch Arthur S Non-Executive Director
895 +81.0%
18.50
US$16,558 		895 +81.0% 18.50 US$16,558
2018-11-15 2018-11-13 B Purchase Kirsch Arthur S Non-Executive Director
105 +10.5%
18.00
US$1,890 		105 +10.5% 18.00 US$1,890
2018-11-13 2018-11-08 B Purchase Kirsch Arthur S Non-Executive Director
1,000 +inf%
18.25
US$18,250 		1,000 +inf% 18.25 US$18,250
2018-08-01 2018-07-30 B Purchase Canaan VIII LP Large shareholder
727,273 +39.6%
11.00
US$8,000,003 		727,273 +39.6% 11.00 US$8,000,003
2018-08-01 2018-07-30 B Purchase SANDELL SCOTT D Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase BASKETT FOREST Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase Bloch Stephen M Non-Executive Director
727,273 +39.6%
11.00
US$8,000,003 		727,273 +39.6% 11.00 US$8,000,003
2018-08-01 2018-07-30 B Purchase BARRIS PETER J Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase New Enterprise Associates 12, Limited Partnership Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase GLAXOSMITHKLINE PLC
148,818 +31.3%
11.00
US$1,636,998 		148,818 +31.3% 11.00 US$1,636,998
2018-08-01 2018-07-30 B Purchase KERINS PATRICK J Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase BARRETT M JAMES Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase Alexandria Venture Investments, LLC Large shareholder
136,364 +52.5%
11.00
US$1,500,004 		136,364 +52.5% 11.00 US$1,500,004
Explore more

More insider trading research around Liquidia Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America